Role of Plasminogen Activator Inhibitor Type 1 (PAI-1) in PCOS Patients

    Shikha Sahay, Madhu Jain, Debabrata Dash … Tara Singh
    Studysummary This study found that women with PCOS had significantly elevated plasma levels of PAI-1, which correlated with insulin resistance and obesity.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ijrcog.org →
    Discuss this study in the Community →